Press release Oncology Venture receives feedback from U.S. FDA on potential approval pathway for Dovitinib.

by NASDAQ Market News March 20, 2020

NASDAQ Market News
Click here to email author

Revive Therapeutics Explores the Use of Bucillamine as a Novel Treatment for Infectious Diseases including COVID-19

Immutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti

Ads